Wendy Sun
About Wendy Sun
Wendy Sun is the Executive Director of Camzyos Marketing at Bristol Myers Squibb, with extensive experience in pharmaceutical marketing, particularly in cardiovascular and dermatology sectors.
Current Role at Bristol Myers Squibb
Wendy Sun currently holds the position of Executive Director of Camzyos Marketing at Bristol Myers Squibb. In this role, she is responsible for overseeing the marketing strategy for CAMZYOS, a transformative therapy for the treatment of obstructive hypertrophic cardiomyopathy. Her leadership has been pivotal in steering this innovative cardiovascular therapy from its inception.
Previous Positions at Bristol Myers Squibb
Wendy Sun has held multiple leadership roles in marketing at Bristol Myers Squibb since joining the company in 2014. She served as Executive Director of U.S. Dermatology Marketing from 2015 to 2017, and Director of Leukemia & Lymphoma US Marketing from 2014 to 2015. In both roles, she contributed to the commercial success of key therapies, including ELIQUIS® and PLAVIX®.
Career at Abbott
Prior to her tenure at Bristol Myers Squibb, Wendy Sun worked at Abbott in various capacities within the Pharmaceutical Products Division. She served as District Sales Manager from 2012 to 2013 and from 2010 to 2012. Additionally, she was a Regional Training Specialist in New Jersey in 2009. Her time at Abbott honed her expertise in pharmaceutical sales and marketing.
Educational Background
Wendy Sun holds an MBA in Marketing and Strategy from the University of Michigan - Ann Arbor, where she studied from 2005 to 2007. She also earned a Bachelor's degree in Economics from Bangkok University, completing her studies from 2001 to 2005. Her academic background laid a strong foundation for her career in pharmaceutical marketing.
Expertise in Pharmaceutical Marketing
Wendy Sun has extensive experience in pharmaceutical marketing, particularly within the cardiovascular and dermatology sectors. Over her six-plus years at Bristol Myers Squibb, she has focused on innovations in cardiovascular healthcare, leading successful marketing strategies for high-profile therapies such as CAMZYOS, ELIQUIS®, and PLAVIX®.